FOUNDATION FOR ADVANCED CARDIOVASCULAR EDUCATION AND TRAINING

THE FOUNDATION PROVIDED ACCREDITATION FOR AND SUPPORTED ADDITIONAL CONTINUING MEDICAL EDUCATION PROGRAMS IN 2024 AS FOLLOWS:ADVANCED HEART - THIS PROGRAM IS DESIGNED TO INCREASE THE PARTICIPANT'S KNOWLEDGE OF CURRENT ADVANCES IN THE DIAGNOSIS AND MANAGEMENT OF HEART FAILURE. THIS CONTINUING EDUCATION ACTIVITY IS INTENDED FOR HOSPITALS, CARDIOLOGISTS, INTERNISTS, GENERAL PRACTIONERS, PHYSICAN ASSISTANTS, NURSE PRACTIONERS, AND NURSES WITH AN INTEREST IN HEART FAILURE CARE.LIVER TRANSPLANT FOR ACUTE ALCOHOLIC HEPATITIS - 2024 CME REGARDING LIVER TRANSPLANTATION AND ETHICS FOR HEALTHCARE PROFESSIONALS.DALLAS ECHO CONFERENCE - THIS MEETING IS AN OPPORTUNITY TO LEARN AND DISCUSS NEW TOPICS IN ECHOCARDIOGRAPHY FOCUSED ON ADVANCED IMAGING AS IT PERTAINS TO EVALUATING AND PREPARING PATIENTS FOR NEW TECHNOLOGIES IN VALVE, HEART FAILURE, AND STRUCTURAL THERAPIES.8TH ANNUAL GYN ONC SYMPOSIUM - 2024 CME REGARDING EDUCATION FOR PHYSICIANS, HEALTHCARE PROFESSIONALS, AND GYNECOLOGIC CANCER SURVIVORS AND CARETAKERS. HEAR FROM A MULTIDISCIPLINARY FACULTY ACROSS THREE SPECIALIZED TRACKS DESIGNED FOR THE UNIQUE INTERESTS OF SPEECH PATHOLOGISTS AND OTOLARYNGOLOGISTS, GASTROENTEROLOGISTS AND PRIMARY CARE PHYSICIANS, OR TECHNICIANS AND NURSES.MED PROFUSION PROGRAM - THIS COURSE WILL INCLUDE CAPTIVATING LECTURES ON BOTH MINIMALLY INVASIVE CARDIAC SURGERY AND EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO). FOCUS WILL BE ON SURGICAL TECHNIQUES AS WELL AS CANNULATION FOR THESE RESPECTIVE PATIENT GROUPS.DALLAS PCI - THIS PROGRAM WILL BE AN INDEPENDANT EDUCATION PROGRAM FOR THE PURPOSE OF EDUCATING PHYSICIANS AND ALLIED HEALTH. FACET, THE PROGRAM COORDINATOR, WILL HAVE THE SOLE RESPONSIBILITY FOR CONTENT AND PROGRAM.DALLAS CV UPDATES - 2025 WILL FEATURE A WIDE VARIETY OF THE LATEST UPDATES IN CONGESTIVE HEART FAILURE, PULMONARY HYPERTENSION, CORONARY ARTERY DISEASE, CARDIAC ARRHYTHMIAS, CONGENITAL HEART DISEASE, ANTICOAGULATION, PREVENTIVE CARDIOLOGY, AND VALVULAR HEART DISEASE, AMONG OTHERS. UPON CONCLUSION OF THIS PROGRAM, PARTICIPANTS SHOULD BE ABLE TO: ASSESS INDICATIONS, USE, AND LIMITATIONS OF DIFFERENT TYPES OF ANTICOAGULANTS IN A DIVERSE SPECTRUM OF CARDIOVASCULAR DISEASES. EVALUATE PERI-PROCEDURE MANAGEMENT OF ANTICOAGULATION IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION. RECITE THE CURRENT INDICATIONS AND CONTRA-INDICATIONS FOR TAVR, MITRAL VALVE CLIP AND POTENTIAL NEW INDICATIONS FOR PERCUTANEOUS TRICUSPID VALVE REPLACEMENT. APPLY THE LATEST HYPERTENSION AND CARDIOVASCULAR (CV) GUIDELINES TO IMPROVE OVERALL MORBIDITY/MORTALITY RATES. DESCRIBE PRACTICE CHANGES TO IMPROVE CARE FOR PATIENTS WITH CONGENITAL HEART DISEASE. SUMMARIZE GUIDELINES TO INCREASE PREVENTIVE CARE FOR PATIENTS WITH CV DISEASES. APPLY CURRENT GUIDELINES FOR THE TREATMENT OF CONGESTIVE HEART FAILURE (CHF). DESCRIBE CLINICAL FEATURES OF PRIMARY PULMONARY ARTERIAL HYPERTENSION. DESCRIBE CARDIOVASCULAR ADAPTATION TO EXERCISE AND REVIEW RISKS AND BENEFITS OF EXERCISE IN PATIENTS WITH CARDIOVASCULAR DISEASES.ERAS SYMPOSIUM - SUCCESSFUL IMPLEMENTATION OF AN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROGRAM REQUIRES A MULTIDISCIPLINARY TEAM EFFORT AND ACTIVE PARTICIPATION OF THE PATIENT IN THE RECOVERY PROGRAM. THE ERAS PROGRAM IS AN OPPORTUNITY TO COLLABORATE WITH LEADING EXPERTS IN THE FIELD WITH A GOAL TO HASTEN FUNCTIONAL RECOVERY AND IMPROVE POSTOPERATIVE OUTCOMES. AFTER ATTENDING THE MEETING, PARTICIPANTS SHOULD BE ABLE TO IDENTIFY AND DISCUSS THE FOLLOWING TOPICS: HOW DOES ERAS VARY FROM SPECIALTY TO SPECIALTY? HOW DOES ERAS COMPLEMENT BSWH STRATEGIES AND VALUES? HOW DO WE LEVERAGE OUR TOOLS AND RESOURCES TO IMPROVE PERIOPERATIVE CARE?DALLAS AORTA - WHILE UNCOMMON, ACUTE AORTIC DISSECTION IS AN INFREQUENT BUT CATASTROPHIC DISORDER. PATIENTS PRESENT WITH TEACH CHEST PAIN THAT RADIATES TO THE BACK. IT IS ESSENTIAL TO BE ABLE TO DIFFERENTIATE AORTIC DISSECTION FROM OTHER CAUSES OF CHEST PAIN. THIS ACTIVITY DESCRIBES THE ETIOLOGY, CLASSIFICATION, PATHOPHYSIOLOGY, EVALUATION, AND MANAGEMENT OF AORTIC DISSECTION, AND HIGHLIGHTS THE ROLE OF INTERPROFESSIONAL TEAMS IN IMPROVING OUTCOMES FOR SUCH PATIENTS. AORTIC DISSECTION IS LIFE THREATENING. THE CONDITION CAN BE MANAGED WITH SURGERY IF IT IS DONE BEFORE THE AORTA RUPTURES. LESS THAN ONE HALF OF PEOPLE WITH A RUPTURED AORTA SURVIVE. THOSE WHO SURVIVE WILL NEED LIFELONG, AGGRESSIVE TREATMENT FOR HIGH BLOOD PRESSURE. THEY WILL NEED TO BE FOLLOWED UP WITH CT SCANS EVERY FEW MONTHS TO MONITOR THE AORTA. WITH PROPER UNDERSTANDING OF THE RISK FACTORS AND PREVENTATIVE CARE, WE CAN DIAGNOSE AND TREAT IT QUICKLY TO SAVE MORE LIVES. UPON COMPLETION OF THIS PROGRAM, PARTICIPANTS SHOULD BE ABLE TO: DISCUSS THE ETIOLOGY, GENETICS, AND IDENTIFICATION OF AORTIC ANEURYSMS; IDENTIFY INDICATION FOR SURGERY, IDENTIFY AORTIC DISSECTION AND OTHER ACUTE AORTOVASCULAR SYNDROMES, AND IMPROVE MANAGEMENT AND SURVEILLANCE OF PATIENTS WITH AORTIC DISEASE.DALLAS SHOCK - THIS SYMPOSIUM, THE FIRST OF ITS KIND FOR THE DALLAS REGION, IS A COLLABORATION OF EXPERTS IN THE CARDIOGENIC SHOCK FIELD, THAT WILL DISCUSS MANY TOPICS INCLUDING IDENTIFYING CARDIOGENIC SHOCK, ADVANCED HEMODYNAMICS REVIEWS, MECHANICAL CIRCULATORY SUPPORT DEVICE TREATMENTS, PHARMACOLOGICAL ADVANCEMENTS, AND THE DEVELOPMENT OF A ROBUST CARDIOGENIC SHOCK PROGRAM. UPON COMPLETION OF THIS PROGRAM, ATTENDEES SHOULD BE ABLE TO: 1. DESCRIBE THE MECHANISMS UNDERLYING CARDIOGENIC SHOCK. 2. IDENTIFY KEY CLINICAL INDICATORS USED FOR EARLY IDENTIFICATION. 3. DIFFERENTIATE THE ROLES OF HEALTHCARE TEAM MEMBERS INVOLVED IN CARDIOGENIC SHOCK MANAGEMENT. 4. EXPLAIN HOW EFFECTIVE COLLABORATION CONTRIBUTES TO THE DEVELOPMENT OF A ROBUST CARDIOGENIC SHOCK PROGRAM. 5. SUMMARIZE CURRENT PHARMACOLOGIC AND MECHANICAL TREATMENTS FOR CARDIOGENIC SHOCK. 6. ANALYZE EMERGING TRENDS IN CLINICAL PRACTICE. LEARNING OBJECTIVE ACHIEVEMENT WILL BE MEASURED WITH THESE QUESTIONS: 1. LIST ONE KEY INDICATOR USED IN IDENTIFYING CARDIOGENIC SHOCK. 2. EXPLAIN ONE ROLE ON THE CARDIOGENIC SHOCK TEAM. 3. IDENTIFY ONE EMERGING TREND YOU WILL APPLY TO YOUR PRACTICE. THIS SEMINAR IS DESIGNED FOR HEALTHCARE PROVIDERS OF ALL LEVELS WHO WANT TO ENHANCE THEIR UNDERSTANDING AND MANAGEMENT OF CARDIOGENIC SHOCK.HEART TRENDING WEBINAR SERIES - THE HEART TRENDING WEBINAR IS A MONTHLY EDUCATIONAL EVENT DESIGNED TO BRING TOGETHER HEALTHCARE PROFESSIONALS, RESEARCHERS, AND CLINICIANS IN THE CARDIOVASCULAR FIELD TO EXPLORE THE LATEST ADVANCEMENTS IN HEART DISEASE MANAGEMENT AND INTERVENTION. THIS INTERACTIVE WEBINAR OFFERS ATTENDEES THE OPPORTUNITY TO HEAR FROM LEADING EXPERTS ON CUTTING-EDGE TOPICS IN CARDIOVASCULAR MEDICINE. EACH SESSION WILL FOCUS ON THE MOST RECENT PUBLICATIONS AND DEVELOPMENTS IN KEY AREAS SUCH AS: INTERVENTIONAL TECHNIQUES (REVIEW OF NEW ADVANCEMENTS AND STRUCTURAL INTERVENTIONS, WITH A PARTICULAR FOCUS ON THEIR CLINICAL APPLICATIONS AND OUTCOMES); ANTIPLATELET THERAPY MANAGEMENT (AN IN-DEPTH EXPLORATION OF THE LATEST EVIDENCE AND GUIDELINES FOR MANAGING ANTIPLATELET THERAPIES IN PATIENTS WITH CORONARY ARTERY DISEASE FOLLOWING CORONARY INTERVENTIONS); TRANSCATHETER AORTIC VALVE REPLACEMENT [TAVR] (DISCUSSING THE EVOLVING LANDSCAPE OF TAVR THERAPIES, EMPHASIZING LONG-TERM MANAGEMENT AND THE MOST CURRENT EVIDENCE TO GUIDE TREATMENT DECISIONS); CORONARY PHYSIOLOGY & IMAGING (UNDERSTANDING THE ROLE OF CORONARY PHYSIOLOGY AND ADVANCED IMAGING TECHNIQUES TO OPTIMIZE OUTCOMES IN BOTH STABLE ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROME). THE HEART TRENDING WEBINAR OFFERS A COMPREHENSIVE PLATFORM FOR LEARNING, DISCUSSION, AND COLLABORATION AMONG PROFESSIONALS DEDICATED TO IMPROVING PATIENT CARE IN CARDIOVASCULAR HEALTH.DALLAS ECMO - LEARN ABOUT EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO). ECMO USES ADVANCED TECHNOLOGY TO PROVIDE TEMPORARY BLOOD CIRCULATION AND RESPIRATORY SUPPORT IN CASES OF LIFE-THREATENING HEART OR LUNG FAILURE WHILE THESE ORGANS RECOVER FROM INJURY, ILLNESS OR A SURGICAL PROCEDURE. ECMO CAN ALSO BE USED AS A LIFE-SUPPORTING, SHORT-TERM BRIDGE TO A HEART TRANSPLANT OR LUNG TRANSPLANT. THE MACHINE REPLACES THE FUNCTION OF THE HEART AND LUNGS FROM A FEW HOURS UP TO MULTIPLE DAYS, DEPENDING ON THE CONDITION AND PROGRESS. UPON COMPLETION OF THIS ACTIVITY, THE ATTENDEES SHOULD BE ABLE TO: UNDERSTAND THE ROLE OF ECMO IN MANAGING COMPLEX CARDIAC CONDITIONS, IDENTIFY THE USE AND EVOLUTION OF ECMO IN RESPIRATORY FAILURE, DISCUSS ESSENTIAL ASPECTS AND MANAGEMENT FOR EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, UNDERSTAND THE PHYSIOLOGICAL CHANGES IN ECMO PATIENTS AND THEIR CLINICAL IMPLICATIONS, DISCUSS THE ROLE AND COMPLEXITIES OF ECMO IN NEONATAL AND PEDIATRIC PATIENTS, ADDRESS THE COMPLEXITIES OF ECMO IN PREGNANT PATIENTS, CONSIDERING BOTH MATERNAL AND FETAL HEALTH, ANALYZE CRITICAL CHALLENGES AND DEBATES IN ECMO MANAGEMENT.